SCHEMBL10967359

SCHEMBL10967359

OC(=S)CCCCc1nc2ccccc2s1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.67
ALOX15 P16050 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
LMNA P02545 1/20 0.58
HPGD P15428 7/20 0.57
RAB9A P51151 1/20 0.57
POLB P06746 1/20 0.55
ATM Q13315 1/20 0.55
DRD2 P14416 3/20 0.53
HTR1A P08908 2/20 0.53
SLC6A4 P31645 2/20 0.53
HTR7 P34969 2/20 0.53
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ALDH1A1 P00352 5/20 0.51
MAPT P10636 2/20 0.51
PKM P14618 2/20 0.51
UBE2T Q9NPD8 1/20 0.50
ASIC3 Q9UHC3 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8593944 0.98 HTT (0.65) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL10967736 0.95 HTT (0.73) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL3060261 0.89 HPGD (0.66) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL6645560 0.85 SMN1; SMN2 (0.91) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL7835167 0.84 SMN1; SMN2 (0.89) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL7835431 0.84 SMN1; SMN2 (0.89) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL27509034 0.84 SMN1; SMN2 (0.68) HTTALOX15SMN1; SMN2LMNAHPGD
Methane SCHEMBL7997331 0.82 SMN1; SMN2 (0.86) HTTALOX15SMN1; SMN2LMNAHPGD
Bromide SCHEMBL11522514 0.82 SMN1; SMN2 (0.66) HTTALOX15SMN1; SMN2LMNAHPGD
SCHEMBL4703104 0.82 HTT (0.71) HTTALOX15SMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0137426-A2 2-Mercaptothiazole derivatives, process for their preparation and utilization of 2-mercaptothiazole derivatives in pharmaceutical compounds BAYER AG (DE) 1985-04-17 EP disclosed